Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate, covering 2020-05-29 to 2020-05-29. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma [Phase 3]

See pricing